PlainRecalls
FDA Drug Low Class III Terminated

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30

Reported: December 9, 2020 Initiated: November 11, 2020 #D-0115-2021

Product Description

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30

Reason for Recall

Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.

Details

Units Affected
N/A
Distribution
Distributed Nationwide in the USA
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30. Recalled by InvaTech Pharma Solutions, LLC. Units affected: N/A.
Why was this product recalled?
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 9, 2020. Severity: Low. Recall number: D-0115-2021.